Anthem's New Pharmacy Networks & Opt Out Home Delivery Program Explained FDA approves weight loss drug Wegovy to lower heart disease risk Wegovy: At least 25,000 people in the US are starting weight loss drug each week, drugmaker says CNN Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head to head trial showing an average weight loss of 20.2% vs. 13.7% Eli Lilly and Company Starting treatment for acne scars, texture, or ongoing breakouts? Know this first: every skin type responds differently, and the right approach is key to real results. Our expert team customizes treatments using